The first human trial of a new schizophrenia drug has yielded promising results, report scientists
We are pleased that there are promising results from this research that may lead to the development of a third generation of drug treatments for schizophrenia
Schizophrenia can be thought of in terms of experiencing episodes during which reality is perceived differently.
Patients treated with "LY2140023" showed improvements in symptoms and few side effects.
There are many antipsychotic drugs available to help alleviate these symptoms, but patients can experience serious side effects such a violent tremor, similar to that experienced by Parkinson's disease sufferers.
For some, the side effects are so distressing that they may stop taking their medicine and risk a relapse.
clipped from: news.bbc.co.uk